Author: Elizabeth Linderbaum

Uncategorized

Sixteenth Street Meets Patient Needs with the Help of 340B

This post is part of NACHC’s 340B Blog Series. The 340B Drug Pricing Program is an essential source of support for Community Health Centers, allowing them to stretch increasingly scarce federal resources and reinvest in patient care. Learn more about 340B and read other blogs in the series. Elizabeth Linderbaum is NACHC’s Deputy Director of Regulatory Affairs. Sixteenth …

Health Center Advocacy, Uncategorized

NACHC Leads Advocacy Efforts to Ensure 30 More Years of 340B

Friday, November 4th marks 30 years since Congress passed legislation codifying the 340B Drug Pricing Program in 1992, naming it after a section of the Public Health Service Act. The 340B Drug Pricing Program was created to assist safety-net providers, like Community Health Centers, “to stretch scarce Federal resources as far as possible, reaching more …

Health Center Advocacy, Health Center Federal Policy, Health Center News, Health Center Regulatory Issues, Uncategorized

340B Spotlight: How 340B Savings Supports Innovation at Carolina Health Centers

Without 340B savings, the health center’s many services that expand access to care — like free prescription deliveries — would be in jeopardy of being rolled back or discontinued.

Health Care News, Health Center Advocacy, Health Center Federal Policy, Health Center Regulatory Issues, Uncategorized

Defending the 340B Program from Every Direction

The 340B Drug Pricing Program has weathered attacks from different health care actors for years. Just months after the outbreak of the COVID-19 pandemic, manufacturers launched attacks by refusing to sell 340B-priced drugs to health centers that use contract pharmacies to increase patient access. This combination of manufacturer restrictions, alongside existing discriminatory contracting actions taken …